FUJIFILM Healthcare Americas Corporation: Device Recall

Recall #Z-2219-2025 · 06/11/2025

Class II: Risk

Recall Details

Recall Number
Z-2219-2025
Classification
Class II
Product Type
Device
Recalling Firm
FUJIFILM Healthcare Americas Corporation
Status
Ongoing
Date Initiated
06/11/2025
Location
Lexington, MA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
293 units

Reason for Recall

Devices had an unapproved slabbing software function enabled for use.

Product Description

ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option (approved under P160031).

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Canada, Chile, Ecuador.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.